Facebook Twitter LinkedIn Google Plus RSS

NPS Pharmaceuticals announces public stock offering

By ,

NPS Pharmaceuticals Inc., of Bedminster, on Monday announced it has begun an underwritten public offering of 6 million shares of its common stock.

According to an announcement, NPS intends to grant its a 30-day option to purchase up to 900,000 additional shares of its common stock to cover over-allotments, if any. The offering is subject to market and other conditions.

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy


Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!